2.5 Gastrointestinal Side Effects Common adverse effects during dose escalation include: Nausea Vomiting Diarrhoea Early satiety Persistent gastrointestinal symptoms may increase the risk of: Reduced caloric intake Reduced protein intake Electrolyte imbalance Dehydration Most symptoms improve with gradual titration and adaptation
So far I havent felt any negative symptoms when using it
Joshua E Meyer, MD Councilor: Margrit M
Do not use over cuts, wounds, inflamed follicles, active infection, irritation, sunburn or broken skin
3 NATiV3 is assessing lanifibranor in 1,009 MASH patients, with expected readouts in the second half of 2026
It is known as a precursor, which means it provides the building blocks your body needs to create its own glutathione